Direkt zum Inhalt
Merck

Beclomethasone dipropionate in the management of rhinitis--a review.

Annals of allergy (1982-09-01)
P Small, M Black, S Frenkiel, G N Wachs
ZUSAMMENFASSUNG

Beclomethasone dipropionate has been demonstrated to be effective in the treatment of seasonal and perennial rhinitis. Comparative studies with other medications are lacking. Adverse reactions are frequent but minor. No alterations of the hypothalamic-pituitary-adrenal axis, nasal mucosal histology or bacterial and fungal flora have been recognized.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

USP
Beclomethasondipropionate, United States Pharmacopeia (USP) Reference Standard
Supelco
Beclomethasondipropionate, analytical standard, for drug analysis
Beclomethasondipropionate, anhydrous, European Pharmacopoeia (EP) Reference Standard
Beclometasondipropionat für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Beclometasondipropionat für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard